Trial Profile
A second phase 1b trial of repeated dosing of higher doses ETV 101 in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Jan 2020
Price :
$35
*
At a glance
- Drugs EVT 101 (Primary)
- Indications Major depressive disorder
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Evotec
- 03 Jul 2008 Status changed from in progress to completed.
- 03 Jul 2008 Top-line results reported in an Evotec media release.
- 20 May 2008 New trial record.